StockData
OnKure Therapeutics, Inc. logo

OnKure Therapeutics, Inc. (OKUR) stock

OKURNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/30
$2.58−0.17 (-6.18%)

Close on Nov 17, 2026Market cap $104.48MP/E –Yield –

OnKure Therapeutics total assets

Total assets on the balance sheet at the end of each period.

OnKure Therapeutics's total assets was $179.35M at Jun 30, 2026. For fiscal 2025 it was $62.12M, down 45.9% from the year before. The highest annual figure on record is $154.02M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$62.12M-45.9%
FY2024Dec 31, 2024$114.91M+221.6%
FY2023Dec 31, 2023$35.73M-67.0%
FY2022Dec 31, 2022$108.18M-29.8%
FY2021Dec 31, 2021$154.02M+178.9%
FY2020Dec 31, 2020$55.22M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$179.35M+108.4%
Q1 FY2026Mar 31, 2026$198.69M+98.9%
Q4 FY2025Dec 31, 2025$62.12M-45.9%
Q3 FY2025Sep 30, 2025$72.84M-6.2%
Q2 FY2025Jun 30, 2025$86.07M+9.3%
Q1 FY2025Mar 31, 2025$99.88M+18.0%
Q4 FY2024Dec 31, 2024$114.91M+221.6%
Q3 FY2024Sep 30, 2024$77.65M-40.5%
Q2 FY2024Jun 30, 2024$78.72M-46.8%
Q1 FY2024Mar 31, 2024$84.64M-14.4%
Q4 FY2023Dec 31, 2023$35.73M-67.0%
Q3 FY2023Sep 30, 2023$130.39M+6.4%
Q2 FY2023Jun 30, 2023$148.04M+10.8%
Q1 FY2023Mar 31, 2023$98.87M-31.5%
Q4 FY2022Dec 31, 2022$108.18M-29.8%
Q3 FY2022Sep 30, 2022$122.50M-24.8%
Q2 FY2022Jun 30, 2022$133.61M-22.0%
Q1 FY2022Mar 31, 2022$144.41M+51.5%
Q4 FY2021Dec 31, 2021$154.02M+178.9%
Q3 FY2021Sep 30, 2021$162.94M–
Q2 FY2021Jun 30, 2021$171.30M–
Q1 FY2021Mar 31, 2021$95.32M–
Q4 FY2020Dec 31, 2020$55.22M–

More OnKure Therapeutics figures

See a number that looks wrong?